Cosmos Health报告,尽管收入略有下降,但Q3收入保持稳定,股本增加。 Cosmos Health reports stable Q3 revenue and increased equity despite slight revenue drop.

据Cosmos Health公司报告,尽管收入和毛利润下降了3.22%,降至1 241万美元,但Q3 2024结果收入和毛利润稳定。 Cosmos Health reported Q3 2024 results with stable revenue and gross profit despite a 3.22% drop to $12.41 million. 公司削减了18.6%的开支,股东的股本增加了8.8%,达到3 500万美元。 The company cut expenses by 18.6% and saw stockholders' equity rise 8.8% to $35 million. 主要重点包括强劲的流动性、超过330万美元的现金以及创纪录的CosmoFarm和亚马逊(联合王国)的销售额。 Key highlights include strong liquidity, over $3.3 million in cash, and record sales at CosmoFarm and Amazon UK. 科斯莫斯健康也进入了新的胃肠道治疗的开发阶段. Cosmos Health also entered the development phase for a new gastrointestinal treatment.